MMP9 and cancer: Identifying MMP9 levels could help pinpoint patients at increased risk of CIPN, highlighting the importance of treatment strategies that account for MMP9’s dual impact on cancer and neuropathy (Tonello et al., 2019; Yang et al., 2019).